Skip to main content
. 2020 Mar 2;52(3):409–422. doi: 10.1038/s12276-020-0390-4

Fig. 3. Silencing of PROM2 induces gemcitabine chemosensitivity in pancreatic cancer cells.

Fig. 3

a Western blot of PROM2 protein expression in indicated cells. b Representative images (left) and quantification data (right) of colony numbers in the indicated cells treated with vehicle or gemcitabine (10 μM) (mean ± SD, n = 3; *P < 0.05). c MTT cell viability assay and IC50 value of gemcitabine (10 μM) in the indicated cells (mean ± SD, n = 3; *P < 0.05). d FACS analysis of Annexin-V and PI staining (left) and quantification (right) of indicated cells treated with Gemcitabine (10 μM) (mean ± SD, n = 3; *P < 0.05).